Campbell & Co Investment Adviser’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-29,649	Closed	-$1.5M	–	1075
2023 Q3	$1.5M	Buy	29,649 +11,699	+65%	+$592K	0.18%	156
2023 Q2	$838K	Buy	+17,950	New	+$838K	0.15%	216